R&D Systems™ Recombinant Human VSIG1 Fc Chimera Protein

Catalog No.	Quantity
97-08V-S050	50 μg

Catalog No. 97-08V-S050 Supplier R&D Systems™ Supplier No. 9708VS050

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

Measured by its ability to inhibit anti-CD3 antibody induced IL-17 secretion by human peripheral blood mononuclear cells (PBMC). The ED50 for this effect is 5-25 μg/mL.

Specifications

• Accession Number: Q86XK7-1
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS.
• Gene ID (Entrez): 340547
• Molecular Weight (g/mol): M.W. (Observed): 68-84 kDa, reducing conditions; M.W. (theoretical): 50 kDa
• Name: Cell surface A33 antigen, dJ889N15.1, Glycoprotein A34, GPA34, MGC44287,1700062D20Rik, V-set and immunoglobulin domain containing 1, V-set and immunoglobulin domain-containing protein 1
• Quantity: 50 μg
• Source: Mouse myeloma cell line, NS0-derived human VSIG1 protein Human VSIG1 (Val22-Gly234) (N-terminus) Accession # Q86XK7-1 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.10 EU / 1 μg of the protein by the LAL method.
• Conjugate: Unconjugated
• Species: Human
• Reconstitution: Reconstitute at 200 μg/mL in PBS.
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.
• Protein: VSIG1